NCM · Medical - Devices

Pulsenmore Ltd. (PLSM) Stock

$1.85 -3.65% NCM: PLSM Healthcare

Valuation

MetricValue
Price$1.85
Market Cap$12.03M
P/E Ratio-0.93
P/B Ratio0.88
P/S Ratio0.95
EPS (TTM)$-2.47
52-Week High$12.97
52-Week Low$1.85
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-69.60%
ROA-45.57%
ROCE-49.22%
Gross Margin-30.00%
Operating Margin-30.00%
Net Margin-101.38%
Debt/Equity0.71
Current Ratio8.10

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.0M$11.0M$6.0M$10.0M$40.0M
Operating Profit$-22.0M$-45.0M$-55.0M$-42.0M$-12.0M
Net Profit$-26.0M$-22.0M$-58.0M$-37.0M$-16.0M
EPS$-5.00$-3.58$-9.07$-5.71$-2.47
Op Margin-1390.2%-427.2%-898.3%-437.0%-30.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$167.0M$231.0M$178.0M$142.0M$102.0M
Total Liabilities$8.0M$49.0M$48.0M$38.0M$19.0M
Cash$113.0M$15.0M$24.0M$41.0M$22.0M
Borrowings$1.0M$7.0M$6.0M$3.0M$2.0M

Latest News

Pulsenmore Shares Soar After Joining Israel’s Healthcare AI Sandbox Programme (PLSM) InvestorsHub · Jul 13, 2026 Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead a $1 Million AI Development Project PR Newswire · Jul 13, 2026 Pulsenmore Files Resale Registration for 3.1 Million Shares MT Newswires · Jul 2, 2026 Pulsenmore to Raise $7.5 Million in Equity Private Placement MT Newswires · Jun 25, 2026 Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor PR Newswire · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-26.0M$-25.0M$-42.0M$-34.0M$-33.0M
Investing Cash Flow$-42.0M$-302.0M$46.0M$50.0M$14.0M
Financing Cash Flow$4.0M$0$-1.0M$-2.0M$1.0M
Net Cash Flow$107.0M$-110.0M$8.0M$17.0M$-20.0M
Free Cash Flow$-27.0M$-29.0M$-46.0M$-34.0M$-33.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.04
EV / EBITDA-1.20
FCF Yield-107.25%
Quick Ratio1.69
Interest Coverage-1.78
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held43.40%
Institutions Held5.21%
Institutions Float Held9.21%
Institutional HolderSharesReport Date
Aquamarine Financial (cayman) Ltd338,5412026-03-31
UBS Group AG3142026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Pulsenmore Ltd.

Pulsenmore Ltd. is led by CEO Elazar Sonnenschein, employs 58 people, headquartered in IL, publicly traded since 2026.

Pulsenmore Ltd. (PLSM) stock trades at $1.85 with a market capitalization of $12.03M. The stock is valued at a price-to-earnings (P/E) ratio of -0.93, price-to-book of 0.88, price-to-sales of 0.95. Over the past 52 weeks the stock has ranged between $1.85 and $12.97, and currently trades 85.7% below its 52-week high.

On profitability, Pulsenmore Ltd. generates a return on equity (ROE) of -69.60%, return on capital employed of -49.22%, an operating margin of -30.00%, a net profit margin of -101.38%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides